Troglitazone directly increases HDL cholesterol levels

被引：17
作者：
Nozue, T [1 ]
Michishita, I [1 ]
Minagawa, F [1 ]
Genda, A [1 ]
机构：
[1] Yokohama Sakae Kyosai Hosp, Dept Internal Med, Sakae Ku, Yokohama, Kanagawa, Japan
来源：
DIABETES CARE | 1999年 / 22卷 / 02期
关键词：
D O I：
10.2337/diacare.22.2.355
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：355 / 356
页数：2
相关论文
共 10 条
  • [1] THE TRIUMVIRATE - BETA-CELL, MUSCLE, LIVER - A COLLUSION RESPONSIBLE FOR NIDDM
    DEFRONZO, RA
    [J]. DIABETES, 1988, 37 (06) : 667 - 687
  • [2] Cardiac and glycemic benefits of troglitazone treatment in NIDDM
    Ghazzi, MN
    Perez, JE
    Autonucci, TK
    Driscoll, JH
    Huang, SM
    Faja, BW
    Whitcomb, RW
    [J]. DIABETES, 1997, 46 (03) : 433 - 439
  • [3] CHANGES IN PREFERENCE
    HANSSON, SO
    [J]. THEORY AND DECISION, 1995, 38 (01) : 1 - 28
  • [4] Iwamoto Y, 1996, DIABETIC MED, V13, P365, DOI 10.1002/(SICI)1096-9136(199604)13:4<365::AID-DIA19>3.0.CO
  • [5] 2-M
  • [6] Effects of troglitazone - A new hypoglycemic agents in patients with NIDDM poorly controlled by diet therapy
    Iwamoto, Y
    Kosaka, K
    Kuzuya, T
    Akanuma, Y
    Shigeta, Y
    Kaneko, T
    [J]. DIABETES CARE, 1996, 19 (02) : 151 - 156
  • [7] Kumar S, 1996, DIABETOLOGIA, V39, P701
  • [8] METABOLIC EFFECTS OF NEW ORAL HYPOGLYCEMIC AGENT CS-045 IN NIDDM SUBJECTS
    SUTER, SL
    NOLAN, JJ
    WALLACE, P
    GUMBINER, B
    OLEFSKY, JM
    [J]. DIABETES CARE, 1992, 15 (02) : 193 - 203
  • [9] VALIQUETT T, 1997, DIABETES S1, V46, pA43
  • [10] YAMADA N, 1993, J CLIN THER MED, V9, P165
1